Gerresheimer AG (GRRMY)
- Previous Close
18.00 - Open
18.00 - Bid --
- Ask --
- Day's Range
18.00 - 18.00 - 52 Week Range
15.35 - 29.22 - Volume
200 - Avg. Volume
357 - Market Cap (intraday)
2.489B - Beta (5Y Monthly) 0.81
- PE Ratio (TTM)
28.12 - EPS (TTM)
0.64 - Earnings Date Jul 9, 2025 - Jul 14, 2025
- Forward Dividend & Yield 0.33 (1.86%)
- Ex-Dividend Date Jun 9, 2025
- 1y Target Est
--
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.
www.gerresheimer.com13,632
Full Time Employees
November 30
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: GRRMY
更多內容Performance Overview: GRRMY
Trailing total returns as of 5/30/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
比較: GRRMY
選擇以關鍵表現數據分析類似公司;最多可選擇 4 個股份。
Statistics: GRRMY
更多內容Valuation Measures
Market Cap
2.49B
Enterprise Value
4.74B
Trailing P/E
28.11
Forward P/E
12.14
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.06
Price/Book (mrq)
1.46
Enterprise Value/Revenue
1.99
Enterprise Value/EBITDA
10.18
Financial Highlights
Profitability and Income Statement
Profit Margin
3.77%
Return on Assets (ttm)
3.01%
Return on Equity (ttm)
5.42%
Revenue (ttm)
2.09B
Net Income Avi to Common (ttm)
78.7M
Diluted EPS (ttm)
0.64
Balance Sheet and Cash Flow
Total Cash (mrq)
150.79M
Total Debt/Equity (mrq)
148.29%
Levered Free Cash Flow (ttm)
-666.52M